29105 Valley Center Rd, Suite 100, Valley Center, CA 92082 | Phone: (760) 749-1156 | Fax: (760) 749-1921 | Mon-Fri 9:00am - 5:30pm | Sat 9:00am - 5:00pm | Sun Closed
Manage your family's medication<br> under one account! Manage your family's medication
under one account!
Register Today!
Stay Healthy <br> We're here to help! Stay Healthy
We're here to help!
Patient Resources
We want your family happy and healthy!<br> Call us today to schedule your vaccination! We want your family happy and healthy!
Call us today to schedule your vaccination!
Your health is our priority.

We take our role in your health very seriously. Come in today to see how we can help.

Download iPhone App Download Google Play App Text Me A Link
Recent health news and videos.

Staying informed is also a great way to stay healthy. Keep up-to-date with all the latest health news here.

12 Sep

Keto Diet Shows Promise in Reducing Depression Among College Students

In a new study, college students with major depressive disorder who followed a keto diet experienced a significant drop in depression symptoms and an increase in overall well-being.

11 Sep

Insomnia May Speed Up Brain Aging and Dementia Risk

A new study suggests chronic insomnia may be an early warning sign or contributor to cognitive decline.

10 Sep

Fall Allergy Survival Guide for Families

Allergies, a cold, or something more? Sorting out the symptoms and treatments with Dr. Farah Kahn, immunologist and allergist at Nationwide Children’s Hospital and a spokesperson for the American College of Allergy, Asthma, and Immunology.

Child in Los Angeles Dies of Rare Brain Disorder Caused by Measles

Child in Los Angeles Dies of Rare Brain Disorder Caused by Measles

A child in Los Angeles County has died from a rare brain disorder caused by a measles infection in infancy, health officials reported.

The child, who was too young to get the measles vaccine, had developed subacute sclerosing panencephalitis (SSPE). It’s a rare complication of measles that causes damage to the brain over time and is ...

  • I. Edwards HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
Dry Eyes Common, But Frequently Left Untreated

Dry Eyes Common, But Frequently Left Untreated

Many folks are needlessly suffering from dry eyes, a new study says.

More than half of people in the U.S. and Europe struggle with dry eyes, in which their eyes fail to produce enough tears to keep them lubricated, researchers reported today at a meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) in Copenhagen.

...

  • Dennis Thompson HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
Smoking Increases Risk Of Type 2 Diabetes

Smoking Increases Risk Of Type 2 Diabetes

Smokers have a higher risk of developing type 2 diabetes, especially if they are genetically predisposed to the condition, a new study says.

People who ever smoked at all have an elevated risk of all four subtypes of type 2 diabetes, and heavy smokers are at even greater risk, researchers reported Saturday at a meeting of the European Asso...

  • Dennis Thompson HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year

Half Of Ozempic Weight-Loss Users Drop The Drug Within A Year

Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says.

About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy) for weight loss stopped taking it after one year, researchers reported Saturday at a meeting of the European Association for the Study of Diabetes in Vienna.

...

  • Dennis Thompson HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
Eye Drops Replacing Reading Glasses? New Study Says It's Possible

Eye Drops Replacing Reading Glasses? New Study Says It's Possible

Instead of searching for reading glasses, could middle-aged folks and seniors soon find themselves rummaging around for a misplaced eye dropper?

Special eye drops used two to three times daily might one day replace reading glasses as a means of coping with age-related vision loss, researchers reported in Copenhagen Sunday at a meeting of t...

  • Dennis Thompson HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
Psilocybin For Depression Effective Up To Five Years After Treatment

Psilocybin For Depression Effective Up To Five Years After Treatment

The benefits of psilocybin treatment for depression might last as long as five years for some, a new study says.

Two-thirds of participants in an early psilocybin clinical trial remained in complete remission from their depression when researchers checked in on them five years later, according to results published in the Journal of Psy...

  • Dennis Thompson HealthDay Reporter
  • |
  • September 15, 2025
  • |
  • Full Page
HealthDay
Health News is provided as a service to Community Pharmacy site users by HealthDay. Community Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2025 HealthDay All Rights Reserved.

Our Affiliations

American Associated Pharmacies
Cardinal Health